- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/80 - Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types
Patent holdings for IPC class G01N 33/80
Total number of patents in this class: 555
10-year publication summary
|
48
|
55
|
62
|
53
|
49
|
42
|
46
|
27
|
40
|
13
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sysmex Corporation | 1418 |
22 |
| Bloodworks | 50 |
18 |
| Labrador Diagnostics LLC | 287 |
16 |
| Iris International, Inc. | 62 |
14 |
| Beckman Coulter, Inc. | 1183 |
11 |
| Assistance Publique - Hopitaux de Paris | 933 |
7 |
| Diagast | 11 |
7 |
| Grifols Diagnostic Solutions Inc. | 44 |
7 |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 1806 |
7 |
| Alentic MicroScience Inc. | 78 |
6 |
| Kellbenx Inc. | 10 |
6 |
| Monash University | 685 |
6 |
| QBD (qs-ip) Limited | 15 |
6 |
| The General Hospital Corporation | 4517 |
5 |
| Chrome Red Technologies, LLC | 9 |
5 |
| Essenlix Corporation, DBA Essenlix Corporation | 266 |
5 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2360 |
5 |
| Medica Corporation | 23 |
5 |
| Life Technologies Corporation | 3068 |
4 |
| Boston Medical Center Corporation | 108 |
4 |
| Other owners | 389 |